Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DYST 203

Next Previous
Drug Profile

DYST 203

Alternative Names: DYST-203

Latest Information Update: 03 Dec 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dystrogen Therapeutics
  • Class Antiepileptic drugs; Gene therapies; Neuroprotectants; Small interfering RNA
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Myoclonic epilepsies

Most Recent Events

  • 29 Nov 2019 Discontinued for Myoclonic epilepsies in USA (Parenteral) (Dystrogen Therapeutics pipeline, November 2019)
  • 24 Jun 2019 Early research in Myoclonic epilepsies in USA (Parenteral) before June 2019 (Dystrogen Therapeutics pipeline, June 2019)
  • 15 May 2018 The Polish Academy of Sciences has patent protection for for nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats worldwide (3389469

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top